Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:26:20.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T13:10:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message, replacing the study content and links with an access-restricted view. This indicates the study record is no longer accessible at this URL.
    Difference
    19%
    Check dated 2026-09-19T18:05:11.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added an NIH grant/contract note for 2014. Updated the page revision to v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T18:50:14.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added and Revision: v3.6.4 has been removed. This reflects a minor version update to the site's revision label, likely a maintenance or platform update rather than content changes.
    Difference
    0.0%
    Check dated 2026-08-08T10:45:23.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, signaling a new build of the page. This update reflects minor maintenance or version control rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-25T06:25:41.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.